Login to Your Account

Pharma: Other news to note

Friday, December 13, 2013
Astellas Pharma U.S. Inc., a subsidiary of Astellas Pharma Inc., of Tokyo, said the Centers for Medicare & Medicaid Services assigned a unique Healthcare Common Procedure Coding System code for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription